SPC333

acalabrutínib eða lyfjafræðilega tækt salt þess

  • Status:
    Veitt
  • Application date:
    26.4.2021
  • Application published:
    15.5.2021
  • Grant published:
    15.1.2023
  • Max expiry date:
    5.11.2035
  • Medicine name:
    Calquence
  • Medicine for children:
    No

Timeline

Today
26.4.2021Application
15.5.2021Publication
15.1.2023Registration
5.11.2035Expires

Marketing license

  • IS authorization number:
    EU/1/20/1479/001-002
  • Date:
    10.11.2020
  • Foreign authorization number:
    EU/1/20/1479
  • Date:
    5.11.2020

Owner

  • Name:
    Merck Sharp & Dohme B.V.
  • Address:
    Waarderweg 39, BN Haarlem NL

Agent

  • Name:
    Kjartan Ragnars, hrl.
  • Address:
    Hrauntungu 66, 200 Kópavogi

Patent

Upload documents